Compound medroxyprogesterone composition for pets and application
A technology of medroxyprogesterone acetate and composition, which is applied in the direction of drug combination, medical raw materials derived from ferns/filamentous plants, and pharmaceutical formulas, which can solve the problem that the effective contraceptive rate of pets cannot be fully guaranteed, and the efficacy of Chinese herbal medicines Mild and slow, low bioavailability of Chinese herbal medicines, etc., to reduce the probability of pet poisoning, economical contraceptive efficacy, and enrich the effect of clinical medication
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1-13
[0049] The prescription (suspension, 1000ml) of an anti-fertility compound medroxyprogesterone acetate composition for pets according to the present invention is shown in Table 1.
[0050] Table 1. Example 1-13 formulations.
[0051]
[0052] Preparation method: Take anhydrous sodium citrate, polyethylene glycol 4000, polysorbate 80, chlorobutanol and water for injection to dissolve in 1000ml, filter, sterilize at 115°C for 30min, and use it as a solvent after cooling. Add prescription amount of medroxyprogesterone acetate, comfrey extract, Example 11-13, and then add Perrin extract, Murata extract or Plantaginaceae extract in the sterile room to prepare suspension, potting in 1ml Available in ampoules.
Embodiment 14
[0053] Example 14: Experimental study on contraception in female mice.
[0054] 1. Experimental design.
[0055] 1.1. Drugs, experimental animal groups and dosing regimens.
[0056] The compound medroxyprogesterone acetate composition preparation is prepared by implementing 2, 5, and 8. Wherein, embodiment 2 contains medroxyprogesterone acetate 18mg / ml, comfrey extract 180mg / ml; embodiment 5 contains medroxyprogesterone acetate 150mg / ml, comfrey extract 100mg / ml; embodiment 8 contains methyl acetate Hydroxyprogesterone 225mg / ml, comfrey extract 15mg / ml; In addition, the single-component comfrey extract (content is 200mg / ml) is prepared with the auxiliary material prescription and preparation method of Example 2, and the auxiliary material prescription and Preparation method Prepare single-component medroxyprogesterone acetate (300mg / ml content), blank suspension (only excipients) and normal saline group.
[0057] Healthy mature Kunming mice, weighing 25-35 g, 840 females an...
Embodiment 15
[0075] Example 15: Research on toxicity of compound medroxyprogesterone acetate to zebrafish.
[0076] 1. Experimental design.
[0077] 1.1. Drugs, experimental animal groups and dosing regimens.
[0078] The compound medroxyprogesterone acetate composition preparation is prepared from implementations 3, 6, and 9. Wherein, embodiment 3 contains medroxyprogesterone acetate 30mg / ml, comfrey extract 150mg / ml; embodiment 6 contains medroxyprogesterone acetate 200mg / ml, comfrey extract 40mg / ml; embodiment 9 contains methyl acetate Hydroxyprogesterone 250mg / ml, comfrey extract 12.5mg / ml; in addition, prepare a single-component comfrey extract (content is 150mg / ml) with the auxiliary material prescription and preparation method of Example 3, and use the auxiliary material prescription of Example 9 And preparation method Prepare single-component medroxyprogesterone acetate (content is 250mg / ml), blank suspension (only containing excipients) and normal saline group.
[0079] Zebrafi...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com